William H Matsui Selected Research

DNA (Deoxyribonucleic Acid)

1/2011

Differentiation therapy in poor risk myeloid malignancies: Results of a dose finding study of the combination bryostatin-1 and GM-CSF.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William H Matsui Research Topics

Disease

8	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019 - 04/2006
6	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 04/2010
3	Multiple Myeloma 01/2019 - 12/2016
3	Neoplasms (Cancer) 10/2016 - 09/2010
2	Infections 01/2017 - 12/2015
1	Fever (Fevers) 10/2018
1	Cytokine Release Syndrome 01/2018
1	Bronchiolitis Obliterans Syndrome 01/2017
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2015
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2014
1	Leukemia 03/2013
1	Burkitt Lymphoma (Burkitt's Lymphoma) 03/2013
1	Hodgkin Disease (Hodgkin's Disease) 05/2012
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2011
1	Acute Promyelocytic Leukemia 01/2011
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2010
1	Aplastic Anemia (Anemia, Hypoplastic) 03/2010
1	Bone Marrow Failure Disorders 03/2010
1	Autoimmune Diseases (Autoimmune Disease) 04/2004
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 04/2004
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 04/2004

Drug/Important Bio-Agent (IBA)

9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 03/2010
3	Rituximab (Mabthera)FDA Link 12/2015 - 04/2004
2	Melphalan (Alkeran)FDA LinkGeneric 01/2019 - 01/2018
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2018 - 01/2018
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2014 - 01/2011
2	Monoclonal AntibodiesIBA 09/2010 - 04/2004
1	HLA-DRB1 Chains (HLA DRB1)IBA 10/2018
1	HLA-A Antigens (HLA-A)IBA 10/2018
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2018
1	tisagenlecleucelIBA 01/2018
1	cyclo(Arg-Pro) (CI 4)IBA 11/2017
1	RetinoidsIBA 12/2016
1	Bortezomib (Velcade)FDA Link 12/2016
1	InterferonsIBA 08/2014
1	Tyrosine Kinase InhibitorsIBA 08/2014
1	Vinblastine (Vinblastine Sulfate)FDA Link 05/2012
1	Bleomycin (Blenoxane)FDA LinkGeneric 05/2012
1	Dacarbazine (DIC)FDA LinkGeneric 05/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2012
1	MethyltransferasesIBA 01/2011
1	DNA (Deoxyribonucleic Acid)IBA 01/2011
1	tigatuzumabIBA 09/2010
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 09/2010
1	Gemcitabine FDA Link 09/2010
1	GPI-Linked ProteinsIBA 04/2004
1	Complement System Proteins (Complement)IBA 04/2004

Therapy/Procedure

7	Transplantation 01/2018 - 04/2010
6	Therapeutics 01/2018 - 03/2010
5	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2019 - 03/2010
2	Stem Cell Transplantation 01/2019 - 01/2018
1	Donor Selection 12/2015
1	Drug Therapy (Chemotherapy) 09/2010
1	Radiotherapy 09/2010
1	Homologous Transplantation 04/2006